Ahmedabad, India-headquartered Intas Pharmaceuticals Ltd., signed an exclusive global licensing deal with Syna Therapeutics, a joint venture of Reig Jofre and Leanbio headquartered at Barcelona Science Park, Spain. Syna will develop and manufacture LB-0702 that is used to treat pathologies in the field of hematology, Intas will commercialize this...